Finally, we presented evidence to indicate that the ER-α (ER-α66), was re-distributed outside of the cell nuclei, and its expression and genomic transcription activity were attenuated in ER-positive breast cancer stem/progenitor cells. This evidence concerns the gene ESR1 and breast carcinoma.